Pure Global

PARSABİV 2.5 MG/0.5 ML I.V. SOLUTION FOR INJECTION, 6 PCS - Turkey License bbce55950c923d6685730caca7bccf4b

Access comprehensive regulatory information for PARSABİV 2.5 MG/0.5 ML I.V. SOLUTION FOR INJECTION, 6 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number bbce55950c923d6685730caca7bccf4b with license number 2019/169and contains active ingredient etelcalcetide hydrochloride . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
bbce55950c923d6685730caca7bccf4b
License Details
Turkey SFDA License: bbce55950c923d6685730caca7bccf4b
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

PARSABİV 2.5 MG/0.5 ML I.V. SOLUTION FOR INJECTION, 6 PCS
TR: PARSABİV 2,5 MG/0,5 ML I.V. ENJEKSİYONLUK ÇÖZELTİ, 6 ADET
Pharmaceutical Product

License Details

bbce55950c923d6685730caca7bccf4b

2019/169

8699862770040

H05BX04

License Holder Information

Active Ingredient

etelcalcetide hydrochloride

License Information

Mar 27, 2019